Monk BJ - Search Results

1

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.

Huh WK, Brady WE, Fracasso PM, Dizon DS, Powell MA, Monk BJ, Leath CA 3rd, Landrum LM, Tanner EJ, Crane EK, Ueda S, McHale MT, Aghajanian C. Huh WK, et al. Among authors: monk bj. Gynecol Oncol. 2020 Sep;158(3):562-569. doi: 10.1016/j.ygyno.2020.06.493. Epub 2020 Jul 6. Gynecol Oncol. 2020. PMID: 32641240 Free PMC article. Clinical Trial.

2

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.

Monk BJ, Alberts DS, Burger RA, Fanta PT, Hallum AV 3rd, Hatch KD, Salmon SE. Monk BJ, et al. Gynecol Oncol. 1998 Nov;71(2):308-12. doi: 10.1006/gyno.1998.5140. Gynecol Oncol. 1998. PMID: 9826477

3

Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.

McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ. McHale MT, et al. Among authors: monk bj. Obstet Gynecol. 2001 Nov;98(5 Pt 1):726-31. doi: 10.1016/s0029-7844(01)01544-7. Obstet Gynecol. 2001. PMID: 11704160

4

Primary invasive vaginal cancer in the setting of the Mayer-Rokitansky-Kuster-Hauser syndrome.

Tewari DS, McHale MT, Kuo JV, Monk BJ, Burger RA. Tewari DS, et al. Among authors: monk bj. Gynecol Oncol. 2002 May;85(2):384-7. doi: 10.1006/gyno.2002.6637. Gynecol Oncol. 2002. PMID: 11972406

5

Development of an in vitro chemo-radiation response assay for cervical carcinoma.

Monk BJ, Burger RA, Parker R, Radany EH, Redpath L, Fruehauf JP. Monk BJ, et al. Gynecol Oncol. 2002 Nov;87(2):193-9. doi: 10.1006/gyno.2002.6818. Gynecol Oncol. 2002. PMID: 12477451

6

Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.

Yessaian A, Magistris A, Burger RA, Monk BJ. Yessaian A, et al. Among authors: monk bj. Gynecol Oncol. 2004 Jul;94(1):61-6. doi: 10.1016/j.ygyno.2004.04.016. Gynecol Oncol. 2004. PMID: 15262120

7

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Muggia FM, Blessing JA, McGehee R, Monk BJ. Muggia FM, et al. Among authors: monk bj. Gynecol Oncol. 2004 Aug;94(2):483-7. doi: 10.1016/j.ygyno.2004.05.018. Gynecol Oncol. 2004. PMID: 15297192 Clinical Trial.

8

Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Morris M, Blessing JA, Monk BJ, McGehee R, Moore DH. Morris M, et al. Among authors: monk bj. J Clin Oncol. 2004 Aug 15;22(16):3340-4. doi: 10.1200/JCO.2004.12.006. J Clin Oncol. 2004. PMID: 15310778 Clinical Trial.

9

Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma.

Chan JK, Sugiyama V, Tajalli TR, Pham H, Gu M, Rutgers J, Monk BJ. Chan JK, et al. Among authors: monk bj. Gynecol Oncol. 2004 Oct;95(1):152-6. doi: 10.1016/j.ygyno.2004.07.004. Gynecol Oncol. 2004. PMID: 15385125

10

Role of pegylated liposomal doxorubicin in ovarian cancer.

Thigpen JT, Aghajanian CA, Alberts DS, Campos SM, Gordon AN, Markman M, McMeekin DS, Monk BJ, Rose PG. Thigpen JT, et al. Among authors: monk bj. Gynecol Oncol. 2005 Jan;96(1):10-8. doi: 10.1016/j.ygyno.2004.09.046. Gynecol Oncol. 2005. PMID: 15589573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters